調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Empty Capsules Market by Type (Gelatin (Porcine, Bovine), Non gelatin (HPMC, Pullulan)), Functionality (Delayed release), Application (Antibiotics, Dietary Supplements, Anti- Inflammatory), End User (Pharma, Nutraceuticals) - Global Forecast to 2026

世界の空カプセル市場予測：種類別、機能性、用途別、エンドユーザー別

◆タイトル：Empty Capsules Market by Type (Gelatin (Porcine, Bovine), Non gelatin (HPMC, Pullulan)), Functionality (Delayed release), Application (Antibiotics, Dietary Supplements, Anti- Inflammatory), End User (Pharma, Nutraceuticals) - Global Forecast to 2026
◆商品コード：PH2935
◆調査・発行会社：MarketsandMarkets
◆発行日：2021年6月25日
◆ページ数：215
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：製薬
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥0見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥0見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥0見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

マーケッツアンドマーケッツ社は空カプセルの世界市場規模が2021年26億ドルから2026年37億ドルまで、年平均7.2％成長すると予想しています。本調査レポートでは、世界の空カプセル市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別（ゼラチン、非ゼラチン）分析、機能性別（即放性ゼラチン、徐放性カプセル、持続放出性カプセル）分析、用途別（抗生物質・抗菌薬、栄養補助食品、制酸薬・制酸薬製剤、抗うつ薬、抗炎症剤、その他）分析、エンドユーザー別（製薬、栄養補助食品、化粧品、研究所）分析、地域別分析、競争状況、企業情報などをまとめております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・空カプセルの世界市場規模：種類別（ゼラチン、非ゼラチン）
・空カプセルの世界市場規模：機能性別（即放性ゼラチン、徐放性カプセル、持続放出性カプセル）
・空カプセルの世界市場規模：用途別（抗生物質・抗菌薬、栄養補助食品、制酸薬・制酸薬製剤、抗うつ薬、抗炎症剤、その他）
・空カプセルの世界市場規模：エンドユーザー別（製薬、栄養補助食品、化粧品、研究所）
・空カプセルの世界市場規模：地域別
・競争状況
・企業情報

“The global empty capsules market is projected to reach USD 3.7 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 7.2% during the forecast period.”
The overall growth of the empty capsules market is largely driven by the growing adoption of capsule formulations among the growing geriatric population, the growth of the pharmaceutical market, increasing R&D activities & clinical trial studies, and advancements in capsule delivery technologies.

“By type, the non-gelatin capsules segment is likely to grow at faster pace”
Based on type, the empty capsules market is categorized into gelatin capsules and non-gelatin capsules. In 2020, gelatin capsules accounted for the largest share in the empty capsules market. The non-gelatin capsules segment is likely to grow at a CAGR of 8.0% during the forecast period. Growth in this segment is largely driven by the increasing demand for non-animal-based products and the advantages offered by these capsules over gelatin-based ones, including low hygroscopicity, physical stability, stability in different ranges of temperature & humidity, and low moisture content.

“Asia Pacific: The fastest-growing region in the empty capsules market.”
The presence of many global capsule manufacturers in China and India, growth in the pharmaceutical and nutraceutical industries, the relatively less stringent regulations in the nutraceutical industry in these regions, an increasing focus on generics, and rising healthcare awareness are expected to drive the adoption of empty capsules in the Asia Pacific.

“North America: the largest share of the empty capsules market”
In 2020, North America accounted for the largest share in the empty capsules market. The large share of this region can be attributed to the existing presence of major capsule manufacturers and pharmaceutical giants. The growing emphasis on superior nutraceutical and cosmetic products has also increased the demand for empty capsules.

Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
By Respondent– Supply Side- 50%, Demand Side- 50%
By Designation—CXOs/Directors- 40%, Managers – 30%, Regional Heads- 30%
By Region— North America – 40%, Europe – 20%, APAC – 20%, RoW- 20%

The empty capsules market is dominated by a few globally established players such as Capsugel (US), ACG Worldwide (India), Qualicaps (US), Suheung Co. Ltd. (Korea), CapsCanada Corporation (Canada), and others

Research Coverage:
The report segments the empty capsules market based on region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), type (gelatin and non-gelatin ), functionality (immediate-release, sustained-release, and delayed-release capsules), therapeutic applications (antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations (hematinic), anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, and other therapeutic applications), end users (pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories).
The report also provides a comprehensive review of market drivers, challenges, and opportunities in the empty capsules market

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the empty capsules market and provides them information on key market drivers, challenges, and opportunities.

【レポートの目次】

1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.2.1 INCLUSIONS & EXCLUSIONS 29
TABLE 1 EMPTY CAPSULES MARKET: INCLUSIONS & EXCLUSIONS 29
1.3 SEGMENTS 29
FIGURE 1 EMPTY CAPSULES MARKET SEGMENTATION 29
FIGURE 2 EMPTY CAPSULES MARKET, BY REGION 30
1.3.1 YEARS CONSIDERED FOR THE STUDY 30
1.4 CURRENCY 31
1.5 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH APPROACH 32
FIGURE 3 RESEARCH DESIGN 32
2.2 PRIMARIES 33
TABLE 2 EMPTY CAPSULES MARKET, PRIMARY RESPONDENTS 33
2.3 TOP-DOWN & BOTTOM-UP APPROACHES 34
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 34
FIGURE 5 REVENUE-BASED MARKET SIZE ESTIMATION 35
2.4 GROWTH FORECAST ASSUMPTIONS 36
2.4.1 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST 36
2.4.1.1 Supply-side assessment 36
2.4.1.2 Demand-side assessment 36
2.4.1.3 Insights from primary experts 37
2.5 DATA TRIANGULATION APPROACH 37
2.5.1 SECONDARY RESEARCH 37
2.5.2 PRIMARY RESEARCH 38
FIGURE 6 DATA TRIANGULATION METHODOLOGY 38
2.6 ASSUMPTIONS 39
2.6.1 COVID-19-SPECIFIC ASSUMPTIONS 39
2.7 LIMITATIONS 40
2.8 RISK ASSESSMENT 40
3 EXECUTIVE SUMMARY 41
FIGURE 7 EMPTY CAPSULES MARKET SHARE, BY TYPE, 2020 VS. 2026 41
FIGURE 8 EMPTY CAPSULES MARKET SHARE, BY FUNCTIONALITY, 2020 42
FIGURE 9 EMPTY CAPSULES MARKET SHARE, BY THERAPEUTIC APPLICATION,
2021 VS. 2026 42
FIGURE 10 EMPTY CAPSULES MARKET SHARE, BY END USER, 2020 43
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE EMPTY CAPSULES MARKET 44
4 PREMIUM INSIGHTS 45
4.1 EMPTY CAPSULES MARKET OVERVIEW 45
FIGURE 12 INCREASING DEMAND FOR NUTRACEUTICALS TO DRIVE MARKET GROWTH 45
4.2 NORTH AMERICA: EMPTY CAPSULES MARKET SHARE, BY TYPE & COUNTRY (2020) 46
FIGURE 13 GELATIN CAPSULES ACCOUNTED FOR THE LARGEST SHARE OF THE
NORTH AMERICAN EMPTY CAPSULES MARKET IN 2020 46
4.3 EMPTY CAPSULES MARKET SHARE, BY FUNCTIONALITY (2020) 46
FIGURE 14 IMMEDIATE-RELEASE CAPSULES HELD THE DOMINANT SHARE OF
THE MARKET IN 2020 46
4.4 EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47
FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE EMPTY CAPSULES MARKET FROM 2021 TO 2026 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
TABLE 3 EMPTY CAPSULES MARKET: IMPACT ANALYSIS OF DRIVERS,
RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48
5.2.1 MARKET DRIVERS 49
5.2.1.1 Increasing demand for nutraceuticals 49
5.2.1.2 Rising geriatric population 49
FIGURE 16 PROJECTED GROWTH IN THE POPULATION AGED 60 AND OLDER,
2015 VS. 2030 VS. 2050 49
FIGURE 17 PROJECTED GROWTH IN THE POPULATION AGED 80 AND OLDER,
2015 VS. 2030 VS. 2050 50
5.2.1.3 Growth in the pharmaceutical market and the increasing number of clinical trials and R&D activities 50
5.2.1.4 Advancements in capsule delivery technologies 51
5.2.2 MARKET RESTRAINTS 51
5.2.2.1 Cultural practices and dietary restrictions 51
5.2.3 MARKET OPPORTUNITIES 52
5.2.3.1 Expansion of capsule production in emerging countries 52
5.2.3.2 Development of halal gelatin and vegetarian capsules 53
5.2.4 MARKET CHALLENGES 53
5.2.4.1 Rising prices and lower availability of raw materials
in the gelatin industry 53
5.3 RANGES/SCENARIOS 54
FIGURE 18 DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE EMPTY CAPSULES MARKET (2020) 54
 
5.4 IMPACT OF COVID-19 ON THE EMPTY CAPSULES MARKET 54
5.4.1 COVID-19 HEALTH ASSESSMENT 54
FIGURE 19 COVID-19: GLOBAL PROPAGATION 55
FIGURE 20 COVID-19 PROPAGATION: SELECT COUNTRIES 55
5.4.2 IMPACT ON THE EMPTY CAPSULES MARKET 56
FIGURE 21 EMPTY CAPSULES MARKET–WITH VS. WITHOUT COVID-19 SCENARIO,
2020 (USD MILLION) 56
5.4.3 IMPACT OF DRIVERS DURING THE COVID-19 PANDEMIC 56
5.5 TRENDS/DISRUPTIONS IMPACTING THE BUSINESS OF CUSTOMERS 57
5.5.1 REVENUE SHIFT & NEW REVENUE POCKETS FOR
EMPTY CAPSULES MANUFACTURERS 57
FIGURE 22 REVENUE SHIFT FOR THE EMPTY CAPSULES MARKET 57
5.6 PRICING ANALYSIS 58
TABLE 4 AVERAGE PRICE OF EMPTY CAPSULES, BY REGION, 2020 58
5.7 ECOSYSTEM/MARKET MAP 59
TABLE 5 EMPTY CAPSULES MARKET ECOSYSTEM 59
5.8 VALUE CHAIN ANALYSIS OF THE EMPTY CAPSULES MARKET 59
5.9 TECHNOLOGICAL ANALYSIS 60
5.9.1 EMPTY CAPSULES 60
5.10 PATENT ANALYSIS 61
FIGURE 23 NUMBER OF PATENTS GRANTED FOR EMPTY CAPSULES, 2010–2020 61
FIGURE 24 REGIONAL ANALYSIS OF PATENTS GRANTED FOR EMPTY CAPSULES, 2020 62
TABLE 6 INDICATIVE LIST OF PATENTS IN THE EMPTY CAPSULES MARKET 62
5.11 TRADE ANALYSIS 63
TABLE 7 EXPORT DATA OF EMPTY CAPSULES FROM INDIA, 2010–2020 63
FIGURE 25 TOP PORTS IN INDIA FOR THE EXPORT OF EMPTY CAPSULES 63
TABLE 8 COUNTRY-WISE EXPORT DATA OF EMPTY CAPSULES
FROM INDIA, 2010–2020 64
TABLE 9 INDIA: IMPORT DATA OF EMPTY CAPSULES 65
FIGURE 26 YEAR-WISE ANALYSIS OF EMPTY CAPSULE IMPORTS TO INDIA, 2010–2020 65
5.12 REGULATORY LANDSCAPE 66
5.13 PORTER’S FIVE FORCES ANALYSIS 68
TABLE 10 EMPTY CAPSULES MARKET: PORTER’S FIVE FORCES ANALYSIS 68
5.13.1 THREAT OF NEW ENTRANTS 68
5.13.2 THREAT OF SUBSTITUTES 68
5.13.3 BARGAINING POWER OF SUPPLIERS 68
5.13.4 BARGAINING POWER OF BUYERS 68
5.13.5 DEGREE OF COMPETITION 69
5.14 PHARMACEUTICAL GELATIN MARKET 69
5.15 INDUSTRY TRENDS 70
FIGURE 27 GROWTH IN THE NUTRACEUTICAL & COSMETIC INDUSTRIES AND INCREASING COLLABORATIONS AMONG EMPTY CAPSULE MANUFACTURERS ARE THE LEADING TRENDS IN THE MARKET 70
5.15.1 RISING DEMAND FOR EMPTY CAPSULES IN THE NUTRACEUTICAL & COSMETIC INDUSTRIES 70
5.15.2 GROWING DEMAND & ADOPTION OF VEGETARIAN/ NON-GELATIN CAPSULES 71
5.15.3 INCREASING COLLABORATIONS AMONG EMPTY CAPSULE MANUFACTURERS 71
6 EMPTY CAPSULES MARKET, BY TYPE 72
6.1 INTRODUCTION 73
TABLE 11 EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 73
TABLE 12 EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (BILLION UNITS) 73
6.2 GELATIN CAPSULES 73
TABLE 13 GELATIN CAPSULES MARKET, BY REGION, 2019–2026 (USD MILLION) 74
TABLE 14 GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION) 75
6.2.1 PORCINE GELATIN 75
6.2.1.1 Porcine gelatin is the most used gelatin type 75
TABLE 15 PORCINE GELATIN MARKET, BY REGION, 2019–2026 (USD MILLION) 76
6.2.2 BOVINE GELATIN 76
6.2.2.1 Bovine gelatin is widely accepted in the halal
pharmaceuticals market 76
TABLE 16 BOVINE GELATIN MARKET, BY REGION, 2019–2026 (USD MILLION) 77
6.2.3 BONE MEAL 77
6.2.3.1 Bone meal gelatin has gained importance in recent years 77
TABLE 17 BONE MEAL MARKET, BY REGION, 2019–2026 (USD MILLION) 78
6.2.4 OTHER GELATIN SOURCES 78
TABLE 18 OTHER GELATIN SOURCES MARKET, BY REGION, 2019–2026 (USD MILLION) 78
6.3 NON-GELATIN CAPSULES 79
TABLE 19 NON-GELATIN CAPSULES MARKET, BY REGION, 2019–2026 (USD MILLION) 79
TABLE 20 NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 80
6.3.1 HYDROXYPROPYL METHYLCELLULOSE 80
6.3.1.1 HPMC dominates the non-gelatin capsules market by raw material 80
TABLE 21 MAJOR PRODUCTS IN THE HPMC MARKET 81
TABLE 22 HYDROXYPROPYL METHYLCELLULOSE MARKET, BY REGION,
2019–2026 (USD MILLION) 82
6.3.2 PULLULAN & STARCH 82
6.3.2.1 High manufacturing costs offset advantageous aspects of
pullulan & starch 82
TABLE 23 PULLULAN & STARCH MARKET, BY REGION, 2019–2026 (USD MILLION) 83
7 EMPTY CAPSULES MARKET, BY FUNCTIONALITY 84
7.1 INTRODUCTION 85
TABLE 24 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION) 85
7.2 IMMEDIATE-RELEASE CAPSULES 85
7.2.1 IMMEDIATE-RELEASE CAPSULES HOLD THE DOMINANT SHARE
OF THE MARKET BY FUNCTIONALITY 85
TABLE 25 IMMEDIATE-RELEASE CAPSULES MARKET, BY REGION,
2019–2026 (USD MILLION) 86
7.3 SUSTAINED-RELEASE CAPSULES 86
7.3.1 THE RISING USE OF SUSTAINED-RELEASE FORMULATIONS IN
TREATING CHRONIC DISEASES DRIVES THE MARKET 86
TABLE 26 SUSTAINED-RELEASE CAPSULES MARKET, BY REGION,
2019–2026 (USD MILLION) 87
7.4 DELAYED-RELEASE CAPSULES 87
7.4.1 GROWING PREFERENCE FOR TARGETED DRUG DELIVERY FAVORS MARKET FOR DELAYED-RELEASE CAPSULES 87
TABLE 27 DELAYED-RELEASE CAPSULES MARKET, BY REGION,
2019–2026 (USD MILLION) 88
8 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION 89
8.1 INTRODUCTION 90
TABLE 28 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,
2019–2026 (USD MILLION) 90
8.2 ANTIBIOTIC & ANTIBACTERIAL DRUGS 90
8.2.1 EMERGENCE OF NOVEL ANTIBIOTICS IN CAPSULE FORM AND INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH 90
TABLE 29 EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS,
BY REGION, 2019–2026 (USD MILLION) 91
8.3 DIETARY SUPPLEMENTS 91
8.3.1 RISING DEMAND FOR DIETARY SUPPLEMENTS TO SUPPORT DEMAND FOR EMPTY CAPSULES 91
TABLE 30 EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION,
2019–2026 (USD MILLION) 92
8.4 ANTACID & ANTIFLATULENT PREPARATIONS 92
8.4.1 INCREASING DEMAND FOR GASTROINTESTINAL FORMULATIONS 92
TABLE 31 EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY REGION, 2019–2026 (USD MILLION) 93
8.5 ANTIANEMIC PREPARATIONS 93
8.5.1 RISING NUMBER OF ANEMIC PATIENTS ACROSS THE GLOBE 93
TABLE 32 EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2019–2026 (USD MILLION) 93
8.6 ANTI-INFLAMMATORY DRUGS 94
8.6.1 RISING EMPHASIS ON GENERICS WILL FAVOR MARKET GROWTH 94
TABLE 33 EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2019–2026 (USD MILLION) 94
8.7 CARDIOVASCULAR THERAPY DRUGS 95
8.7.1 THE RISING PREVALENCE OF CARDIOVASCULAR DISEASES
CONTRIBUTES TO MARKET GROWTH 95
TABLE 34 EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS,
BY REGION, 2019–2026 (USD MILLION) 95
8.8 COUGH & COLD DRUGS 96
8.8.1 THE GROWING ADOPTION OF OTC FORMULATIONS AND SELF-MEDICATION PRACTICES T0 DRIVE MARKET GROWTH 96
TABLE 35 EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY REGION,
2019–2026 (USD MILLION) 96
8.9 OTHER THERAPEUTIC APPLICATIONS 96
TABLE 36 EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION) 97
9 EMPTY CAPSULES MARKET, BY END USER 98
9.1 INTRODUCTION 99
TABLE 37 EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION) 99
9.2 PHARMACEUTICAL INDUSTRY 99
9.2.1 GROWING EMPHASIS ON DRUG DEVELOPMENT IS DRIVING THE MARKET 99
TABLE 38 EMPTY CAPSULES MARKET FOR THE PHARMACEUTICAL INDUSTRY,
BY REGION, 2019–2026 (USD MILLION) 100
9.3 NUTRACEUTICAL INDUSTRY 100
9.3.1 GROWING DEMAND FOR DIETARY SUPPLEMENTS IN DEVELOPED & DEVELOPING COUNTRIES 100
TABLE 39 EMPTY CAPSULES MARKET FOR THE NUTRACEUTICAL INDUSTRY, BY REGION, 2019–2026 (USD MILLION) 101
9.4 COSMETIC INDUSTRY 101
9.4.1 GELATIN-BASED CAPSULES ARE IDEAL FOR DELIVERING
COSMETIC PRODUCTS 101
TABLE 40 EMPTY CAPSULES MARKET FOR THE COSMETIC INDUSTRY, BY REGION, 2019–2026 (USD MILLION) 102
9.5 RESEARCH LABORATORIES 102
9.5.1 RISING CLINICAL TRIAL ACTIVITY IS A KEY DRIVER OF MARKET GROWTH 102
TABLE 41 EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION, 2019–2026 (USD MILLION) 103
10 EMPTY CAPSULES MARKET, BY REGION 104
10.1 INTRODUCTION 105
FIGURE 28 EMPTY CAPSULES MARKET: REGIONAL SNAPSHOT (2020 VS 2026) 105
TABLE 42 EMPTY CAPSULES MARKET, BY REGION, 2019–2026 (USD MILLION) 106
TABLE 43 EMPTY CAPSULES MARKET, BY REGION, 2019–2026 (BILLION UNITS) 106
10.2 NORTH AMERICA 107
FIGURE 29 EMPTY CAPSULES MARKET: NORTH AMERICA SNAPSHOT 108
TABLE 44 NORTH AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
TABLE 45 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 109
TABLE 46 NORTH AMERICA: GELATIN CAPSULES MARKET, BY SOURCE,
2019–2026 (USD MILLION) 109
TABLE 47 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 109
TABLE 48 NORTH AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 110
TABLE 49 NORTH AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION) 110
TABLE 50 NORTH AMERICA: EMPTY CAPSULES MARKET, BY END USER,
2019–2026 (USD MILLION) 110
10.2.1 US 111
10.2.1.1 The US dominates the North American market for empty capsules 111
TABLE 51 US: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 111
TABLE 52 US: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION) 112
TABLE 53 US: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 112
TABLE 54 US: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 112
TABLE 55 US: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,
2019–2026 (USD MILLION) 113
TABLE 56 US: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION) 113
10.2.2 CANADA 113
10.2.2.1 Rising government focus on the utilization of generics as a means for controlling healthcare expenditure in the country 113
TABLE 57 CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 114
TABLE 58 CANADA: GELATIN CAPSULES MARKET, BY SOURCE,
2019–2026 (USD MILLION) 115
TABLE 59 CANADA: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 115
TABLE 60 CANADA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 115
TABLE 61 CANADA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,
2019–2026 (USD MILLION) 116
TABLE 62 CANADA: EMPTY CAPSULES MARKET, BY END USER,
2019–2026 (USD MILLION) 116
10.3 EUROPE 116
TABLE 63 EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 117
TABLE 64 EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 117
TABLE 65 EUROPE: GELATIN CAPSULES MARKET, BY SOURCE,
2019–2026 (USD MILLION) 117
TABLE 66 EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 118
TABLE 67 EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 118
TABLE 68 EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,
2019–2026 (USD MILLION) 118
TABLE 69 EUROPE: EMPTY CAPSULES MARKET, BY END USER,
2019–2026 (USD MILLION) 119
10.3.1 GERMANY 119
10.3.1.1 The presence of many pharmaceutical and nutraceutical manufacturers is propelling the demand for empty capsules 119
TABLE 70 GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 120
TABLE 71 GERMANY: GELATIN CAPSULES MARKET, BY SOURCE,
2019–2026 (USD MILLION) 120
TABLE 72 GERMANY: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 120
TABLE 73 GERMANY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 120
TABLE 74 GERMANY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION) 121
TABLE 75 GERMANY: EMPTY CAPSULES MARKET, BY END USER,
2019–2026 (USD MILLION) 121
10.3.2 UK 121
10.3.2.1 Rising adoption of generics favors market growth in the UK 121
TABLE 76 UK: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 122
TABLE 77 UK: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION) 122
TABLE 78 UK: NON-GELATIN CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 122
TABLE 79 UK: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 123
TABLE 80 UK: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,
2019–2026 (USD MILLION) 123
TABLE 81 UK: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION) 123
10.3.3 FRANCE 124
10.3.3.1 The large demand for pharmaceutical products in France is increasing the demand for empty capsules 124
TABLE 82 FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 124
TABLE 83 FRANCE: GELATIN CAPSULES MARKET, BY SOURCE,
2019–2026 (USD MILLION) 124
TABLE 84 FRANCE: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 85 FRANCE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 125
TABLE 86 FRANCE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,
2019–2026 (USD MILLION) 125
TABLE 87 FRANCE: EMPTY CAPSULES MARKET, BY END USER,
2019–2026 (USD MILLION) 126
10.3.4 ITALY 126
10.3.4.1 Growing presence of small to medium-sized CMOs likely to drive the Italian pharmaceutical industry 126
TABLE 88 ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 127
TABLE 89 ITALY: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION) 127
TABLE 90 ITALY: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 91 ITALY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 127
TABLE 92 ITALY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,
2019–2026 (USD MILLION) 128
TABLE 93 ITALY: EMPTY CAPSULES MARKET, BY END USER,
2019–2026 (USD MILLION) 128
10.3.5 SPAIN 128
10.3.5.1 Consolidation of the biotechnology sector, availability of
government support 128
TABLE 94 SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 129
TABLE 95 SPAIN: GELATIN CAPSULES MARKET, BY SOURCE,
2019–2026 (USD MILLION) 129
TABLE 96 SPAIN: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 129
TABLE 97 SPAIN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 130
TABLE 98 SPAIN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,
2019–2026 (USD MILLION) 130
TABLE 99 SPAIN: EMPTY CAPSULES MARKET, BY END USER,
2019–2026 (USD MILLION) 130
10.3.6 ROE 131
TABLE 100 ROE: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 131
TABLE 101 ROE: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION) 131
TABLE 102 ROE: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 132
TABLE 103 ROE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 132
TABLE 104 ROE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,
2019–2026 (USD MILLION) 132
TABLE 105 ROE: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION) 133
10.4 ASIA PACIFIC 133
FIGURE 30 EMPTY CAPSULES MARKET: ASIA PACIFIC SNAPSHOT 134
TABLE 106 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 135
TABLE 107 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 108 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY SOURCE,
2019–2026 (USD MILLION) 135
TABLE 109 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 136
TABLE 110 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 136
TABLE 111 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION) 136
TABLE 112 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER,
2019–2026 (USD MILLION) 137
10.4.1 JAPAN 137
10.4.1.1 Japan is the largest market for empty capsules in APAC 137
TABLE 113 JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 114 JAPAN: GELATIN CAPSULES MARKET, BY SOURCE,
2019–2026 (USD MILLION) 138
TABLE 115 JAPAN: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 116 JAPAN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 138
TABLE 117 JAPAN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,
2019–2026 (USD MILLION) 139
TABLE 118 JAPAN: EMPTY CAPSULES MARKET, BY END USER,
2019–2026 (USD MILLION) 139
10.4.2 CHINA 139
10.4.2.1 Low manufacturing costs on account of the availability of raw materials to accelerate the growth of this market 139
TABLE 119 CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 140
TABLE 120 CHINA: GELATIN CAPSULES MARKET, BY SOURCE,
2019–2026 (USD MILLION) 141
TABLE 121 CHINA: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 122 CHINA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 141
TABLE 123 CHINA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,
2019–2026 (USD MILLION) 142
TABLE 124 CHINA: EMPTY CAPSULES MARKET, BY END USER,
2019–2026 (USD MILLION) 142
10.4.3 INDIA 142
10.4.3.1 Increased exports of empty capsules to drive market growth in India 142
TABLE 125 INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 126 INDIA: GELATIN CAPSULES MARKET, BY SOURCE,
2019–2026 (USD MILLION) 143
TABLE 127 INDIA: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 128 INDIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 144
TABLE 129 INDIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,
2019–2026 (USD MILLION) 144
TABLE 130 INDIA: EMPTY CAPSULES MARKET, BY END USER,
2019–2026 (USD MILLION) 145
10.4.4 ROAPAC 145
TABLE 131 ROAPAC: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 132 ROAPAC: GELATIN CAPSULES MARKET, BY SOURCE,
2019–2026 (USD MILLION) 146
TABLE 133 ROAPAC: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 134 ROAPAC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 146
TABLE 135 ROAPAC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,
2019–2026 (USD MILLION) 147
TABLE 136 ROAPAC: EMPTY CAPSULES MARKET, BY END USER,
2019–2026 (USD MILLION) 147
10.5 LATIN AMERICA 147
10.5.1 EXPANSION BY LEADING MARKET PLAYERS IN THE REGION TO
DRIVE MARKET GROWTH 147
TABLE 137 LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 138 LATIN AMERICA: GELATIN CAPSULES MARKET, BY SOURCE,
2019–2026 (USD MILLION) 148
TABLE 139 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 140 LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 149
TABLE 141 LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2019–2026 (USD MILLION) 149
TABLE 142 LATTIN AMERICA: EMPTY CAPSULES MARKET, BY END USER,
2019–2026 (USD MILLION) 149
10.6 MIDDLE EAST & AFRICA 150
10.6.1 GROWING PHARMACEUTICAL INDUSTRY IN MEA TO DRIVE MARKET GROWTH 150
TABLE 143 MEA: EMPTY CAPSULES MARKET, BY TYPE, 2019–2026 (USD MILLION) 150
TABLE 144 MEA: GELATIN CAPSULES MARKET, BY SOURCE, 2019–2026 (USD MILLION) 151
TABLE 145 MEA: NON-GELATIN CAPSULES MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 146 MEA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY,
2019–2026 (USD MILLION) 151
TABLE 147 MEA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION,
2019–2026 (USD MILLION) 152
TABLE 148 MEA: EMPTY CAPSULES MARKET, BY END USER, 2019–2026 (USD MILLION) 152
11 COMPETITIVE LANDSCAPE 153
11.1 INTRODUCTION 153
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY MARKET PLAYERS 153
11.3 REVENUE ANALYSIS 154
FIGURE 31 REVENUE ANALYSIS FOR KEY COMPANIES OVER THE PAST THREE YEARS 154
11.4 MARKET SHARE ANALYSIS 155
FIGURE 32 EMPTY CAPSULES MARKET: MARKET SHARE ANALYSIS OF
KEY PLAYERS (2020) 155
11.5 COMPANY EVALUATION QUADRANT 156
11.5.1 STARS 156
11.5.2 EMERGING LEADERS 156
11.5.3 PERVASIVE PLAYERS 156
11.5.4 PARTICIPANTS 156
FIGURE 33 EMPTY CAPSULES MARKET: COMPANY EVALUATION QUADRANT, 2020 157
11.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES 157
11.6.1 PROGRESSIVE COMPANIES 157
11.6.2 STARTING BLOCKS 158
11.6.3 RESPONSIVE COMPANIES 158
11.6.4 DYNAMIC COMPANIES 158
FIGURE 34 EMPTY CAPSULES MARKET: COMPANY EVALUATION QUADRANT
FOR START-UPS/SMES, 2020 159
11.7 COMPETITIVE BENCHMARKING 160
FIGURE 35 COMPANY PRODUCT FOOTPRINT (25 COMPANIES) 160
TABLE 149 COMPANY INDUSTRY FOOTPRINT (25 COMPANIES) 161
TABLE 150 COMPANY REGION FOOTPRINT (25 COMPANIES) 162
TABLE 151 COMPANY OFFERING FOOTPRINT (25 COMPANIES) 163
11.8 GROWTH STRATEGIES ADOPTED BY MAJOR AND EMERGING PLAYERS 164
11.8.1 EMPTY CAPSULES MARKET: KEY DEALS (JANUARY 2018 TO JUNE 2021) 164
12 COMPANY PROFILES 166
12.1 KEY MARKET PLAYERS 166
(Business Overview, Products Offered, Recent Developments, and MnM View)*
12.1.1 CAPSUGEL (LONZA GROUP LTD.) 166
TABLE 152 CAPSUGEL (LONZA GROUP): BUSINESS OVERVIEW 166
FIGURE 36 LONZA GROUP LTD.: COMPANY SNAPSHOT (2020) 167
12.1.2 ACG 170
TABLE 153 ACG: BUSINESS OVERVIEW 170
12.1.3 MITSUBISHI CHEMICAL HOLDINGS CORPORATION 173
TABLE 154 QUALICAPS (MITSUBISHI CHEMICAL HOLDINGS CORPORATION):
BUSINESS OVERVIEW 173
FIGURE 37 MITSUBISHI CHEMICAL HOLDINGS CORPORATION:
COMPANY SNAPSHOT (2020) 174
12.1.4 SUHEUNG 177
TABLE 155 SUHEUNG: BUSINESS OVERVIEW 177
12.1.5 CAPSCANADA CORPORATION 179
TABLE 156 CAPSCANADA CORPORATION: BUSINESS OVERVIEW 179
12.1.6 QINGDAO YIQING MEDICINAL CAPSULE 181
TABLE 157 QINGDAO YIQING MEDICINAL CAPSULES: BUSINESS OVERVIEW 181
12.1.7 SHANXI GUANGSHENG MEDICINAL CAPSULE 186
TABLE 158 SHANXI GUANGSHENG MEDICINAL CAPSULE: BUSINESS OVERVIEW 186
12.1.8 HEALTH CAPS INDIA 187
TABLE 159 HEALTH CAPS INDIA: BUSINESS OVERVIEW 187
12.1.9 SNAIL PHARMA INDUSTRY 189
TABLE 160 SNAIL PHARMA INDUSTRY: BUSINESS OVERVIEW 189
12.1.10 ROXLOR 190
TABLE 161 ROXLOR: BUSINESS OVERVIEW 190
12.1.11 SUNIL HEALTHCARE 191
TABLE 162 SUNIL HEALTHCARE: BUSINESS OVERVIEW 191
FIGURE 38 SUNIL HEALTHCARE: COMPANY SNAPSHOT (2020) 192
12.1.12 MEDI-CAPS 194
TABLE 163 MEDI-CAPS: BUSINESS OVERVIEW 194
FIGURE 39 MEDI-CAPS: COMPANY SNAPSHOT (2020) 194
12.1.13 NECTAR LIFESCIENCES 196
TABLE 164 NECTAR LIFESCIENCES: BUSINESS OVERVIEW 196
FIGURE 40 NECTAR LIFESCIENCES: COMPANY SNAPSHOT (2020) 196
12.1.14 NATURAL CAPSULES 198
TABLE 165 NATURAL CAPSULES: BUSINESS OVERVIEW 198
FIGURE 41 NATURAL CAPSULES: COMPANY SNAPSHOT (2020) 198
12.1.15 BRIGHT PHARMA CAPS 200
TABLE 166 BRIGHT PHARMA CAPS: BUSINESS OVERVIEW 200
12.2 OTHER MARKET PLAYERS 202
12.2.1 ERAWAT PHARMA LIMITED 202
TABLE 167 ERAWAT PHARMA LIMITED: BUSINESS OVERVIEW 202
12.2.2 COMED CHEMICALS 203
TABLE 168 COMED CHEMICALS: BUSINESS OVERVIEW 203
12.2.3 FORTCAPS HEALTHCARE 204
TABLE 169 FORTCAPS HEALTHCARE: BUSINESS OVERVIEW 204
12.2.4 SHAOXING ZHONGYA CAPSULE 206
TABLE 170 SHAOXING ZHONGYA CAPSULE: BUSINESS OVERVIEW 206
12.2.5 FARMACAPSULAS 208
TABLE 171 FARMACAPSULAS: BUSINESS OVERVIEW 208
12.2.6 SHREE PHARMA CAPS 210
TABLE 172 SHREE PHARMA CAPS: COMPANY OVERVIEW 210
12.2.7 LFA MACHINES OXFORD 211
TABLE 173 LFA MACHINES OXFORD: COMPANY OVERVIEW 211
12.2.8 SHAOXING KANGKE CAPSULE 212
TABLE 174 SHAOXING KANGKE CAPSULE: COMPANY OVERVIEW 212
12.2.9 ZHEJIANG YUEXI CAPSULE 212
TABLE 175 ZHEJIANG YUEXI CAPSULE: COMPANY OVERVIEW 212
12.2.10 SAVIOUR CAPS 213
TABLE 176 SAVIOUR CAPS: COMPANY OVERVIEW 213
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX 214
13.1 DISCUSSION GUIDE 214
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 218
13.3 AVAILABLE CUSTOMIZATIONS 220
13.4 RELATED REPORTS 220
13.5 AUTHOR DETAILS 221



★調査レポート[世界の空カプセル市場予測：種類別、機能性、用途別、エンドユーザー別] ( Empty Capsules Market by Type (Gelatin (Porcine, Bovine), Non gelatin (HPMC, Pullulan)), Functionality (Delayed release), Application (Antibiotics, Dietary Supplements, Anti- Inflammatory), End User (Pharma, Nutraceuticals) - Global Forecast to 2026 / PH2935) 販売に関する免責事項
[世界の空カプセル市場予測：種類別、機能性、用途別、エンドユーザー別] ( Empty Capsules Market by Type (Gelatin (Porcine, Bovine), Non gelatin (HPMC, Pullulan)), Functionality (Delayed release), Application (Antibiotics, Dietary Supplements, Anti- Inflammatory), End User (Pharma, Nutraceuticals) - Global Forecast to 2026 / PH2935) についてEメールでお問い合わせ
◆関連調査資料◆
  • 世界のマイクロキャリア市場予測：機器別、消耗品別、マイクロキャリア別、用途別、エンドユーザー別
    BT6423 / MarketsandMarkets / 2021年3月22日 / マーケッツアンドマーケッツ社は、世界のマイクロキャリア市場規模が2021年17億ドルから2026年29億ドルまで、年平均10.7%成長すると予測しています。本調査資料では、マイクロキャリアの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（消耗品、機器）分析、用途別（医薬品製造、細胞・遺伝子治療、組織エンジニアリング・再生医療、その他）分析、用途別（半導体、生命科学、材料科学、その他）分析、エンドユーザー別（医薬品＆バイオ医薬品、CRO＆CMO、学術・研究機関、細胞バンク）分析、地域別分析、競争状況、企業情報などを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・世界のマイクロキャリア市場規模：製品別（消耗品、機器） ・世界のマイクロキャリア市場規模：用途別（医薬品製造、細胞・遺伝子治療、組織エンジニアリング・再生医療、その他） ・世界のマイクロキャリア市場規模：エンドユーザー別（医薬品＆バイオ医薬品、CRO＆CMO、学術・研究機関、細胞バンク） ・世界のマイクロキャリア市場規模：地域別...“The microcarriers market is projected to reach USD 2.9 billion by 2026 from USD 1.7 billion in 2021, at a CAGR of 10.7% during the forecast period.” Increasing use of single-use bioreactors for bioprocessing, rising investmnet in R&D for developemnt of vaccines and therapeutic protiens, and increasing government funding for cell and gene therapy. “By product, the consumables segment accounted for the largest share of the microcarriers market” The microcarriers market by product is categorized into major consuambles and equipments. Consumables dominated the market in 2020. The large share of this segment can be attributed to rising awareness about advantages...
  • 世界のマイクロプレートシステム市場予測：製品別、用途別、エンドユーザー別
    MD5992 / MarketsandMarkets / 2021年6月28日 / マーケッツアンドマーケッツ社はマイクロプレートシステムの世界市場規模が2021年927百万ドルから2026年1,170百万ドルまで、年平均4.8％成長すると予想しています。本調査レポートでは、世界のマイクロプレートシステム市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（マイクロプレートリーダー、マイクロプレートピペットシステム・ディスペンサー、マイクロプレートウォッシャー、マイクロプレート付属品・ソフトウェア）分析、用途別（創薬、臨床診断、ゲノミクス・プロテオミクス研究、その他）分析、エンドユーザー別（バイオテクノロジー・製薬企業、病院・診断研究所、学術・研究機関）分析、地域別分析、競争状況、企業情報などをまとめております。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・マイクロプレートシステムの世界市場規模：製品別（マイクロプレートリーダー、マイクロプレートピペットシステム・ディスペンサー、マイクロプレートウォッシャー、マイクロプレート付属品・ソフトウェア） ・マイクロプレートシステムの世界市場規模：用途別（創薬、臨床診断、ゲノミクス・プロテオミクス研究、その他） ・マイクロプレートシステムの世界市場規模：エンドユーザー別（バイオテクノロジー・製薬企業、病院・診断研究所、学術・研究機関） ・マイクロプレートシステムの世界市場規模：地域別...“The global microplate systems market size is projected to reach USD 1,170 million by 2026 from USD 927 million in 2021, at a CAGR of 4.8% from 2021 to 2026.” Growth in this market is driven by the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, and the growing prevalence of diseases “Microplate readers segment to witness the highest growth during the forecast period.” Based on the product, the microplate systems market is segmented into microplate readers, microplate pipetting systems and dispensers, microplate washers, and microplate accessories & software. The consumables segment is projected to grow at...
  • 世界の細胞解離市場予測：製品別、種類別、組織別、エンドユーザー別
    BT6129 / MarketsandMarkets / 2021年5月11日 / マーケッツアンドマーケッツ社は世界の細胞解離市場規模が2021年282百万ドルから2026年561百万ドルまで、年平均14.7%成長すると予測しています。本調査レポートでは、細胞解離の世界市場について調査・分析し、イントロダクション、調査手法、市場概要、エグゼクティブサマリー、プレミアムインサイト、製品別（細胞解離製品、非細胞解離製品、器具・付属品）分析、組織別（結合組織、上皮組織、その他）分析、種類別（組織解離、細胞剥離）分析、エンドユーザー別（製薬・バイオテクノロジー企業、研究・学術機関、その他）分析、地域別分析、競争状況、企業情報などを掲載しております。 ・イントロダクション ・調査手法 ・市場概要 ・エグゼクティブサマリー ・プレミアムインサイト ・世界の細胞解離市場規模：製品別（細胞解離製品、非細胞解離製品、器具・付属品） ・世界の細胞解離市場規模：組織別（結合組織、上皮組織、その他） ・世界の細胞解離市場規模：種類別（組織解離、細胞剥離） ・世界の細胞解離市場規模：エンドユーザー別（製薬・バイオテクノロジー企業、研究・学術機関、その他）...“The global cell dissociation market size is projected to reach USD 561 million by 2026 from USD 282 million in 2021, at a CAGR of 14.7% during the forecast period.” The growth in this market is attributed to the prevalence of cell based research, the increasing number of pharmaceutical and biotechnology companies. Moreover, the growth opportunities in emerging markets are expected to provide growth opportunities for players in the cell dissociation market during the forecast period. “Enzymatic dissociation products segment to witness the highest growth during the forecast period.” Based on the product, the cell dissociation market is segmented into...
  • 世界の患者由来異種移植/PDXモデル市場予測：種類別、腫瘍タイプ別、用途別、エンドユーザー別
    BT5576 / MarketsandMarkets / 2029年4月23日 / マーケッツアンドマーケッツ社は、世界の患者由来異種移植/PDXモデル市場規模が2021年140百万ドルから2026年299百万ドルまで、年平均16.4％成長すると予測しています。本調査レポートでは、患者由来異種移植/PDXモデルの世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別（マウスモデル、ラットモデル）分析、腫瘍タイプ別（消化管腫瘍モデル、婦人科腫瘍モデル、呼吸器腫瘍モデル、泌尿器腫瘍モデル、血液腫瘍モデル）分析、用途別（前臨床医薬品開発、バイオマーカー分析、がん基本研究）分析、エンドユーザー別（製薬＆バイオテクノロジー、委託研究機関、学術＆研究機関）分析、地域別分析、競争状況、企業情報などを整理しました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・世界の患者由来異種移植/PDXモデル市場規模：種類別（マウスモデル、ラットモデル） ・世界の患者由来異種移植/PDXモデル市場規模：腫瘍タイプ別（消化管腫瘍モデル、婦人科腫瘍モデル、呼吸器腫瘍モデル、泌尿器腫瘍モデル、血液腫瘍モデル） ・世界の患者由来異種移植/PDXモデル市場規模：用途別（前臨床医薬品開発、バイオマーカー分析、がん基本研究） ・世界の患者由来異種移植/PDXモデル市場規模：エンドユーザー別（製薬＆バイオテクノロジー、委託研究機関、学術＆研究機関）...“The global Patient-Derived Xenograft/PDX models market size is projected to reach USD 299 million by 2026 from USD 140 million in 2021, at a CAGR of 16.4% during the forecast period.” Market growth is driven mainly by factors such as growing demand for personalized medicine, continuous support for cancer research, and growth in pharma R&D. Rising demand for humanized PDX models is expected to provide growth opportunity for players in the PDX models market. However, the high cost of personalized PDX models, stringent guidelines regarding the ethical use of animals in cancer research, and limitations associated with PDX models are...
  • 世界の医療用テープ・包帯市場予測：製品別、用途別、エンドユーザー別
    MD5444 / MarketsandMarkets / 2021年5月10日 / マーケッツアンドマーケッツ社は世界の医療用テープ・包帯市場規模が2021年71億ドルから2026年86億ドルまで、年平均4.0%成長すると予測しています。本調査レポートでは、医療用テープ・包帯の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（包帯、医療用テープ）分析、用途別（外科的創傷治療、外傷性創傷治療、潰瘍治療、スポーツ損傷治療、火傷治療、その他）分析、エンドユーザー別（病院、ASC、クリニック、在宅医療、その他）分析、地域別分析、競争状況、企業情報、隣接/関連市場などを掲載しております。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・世界の医療用テープ・包帯市場規模：製品別（包帯、医療用テープ） ・世界の医療用テープ・包帯市場規模：用途別（外科的創傷治療、外傷性創傷治療、潰瘍治療、スポーツ損傷治療、火傷治療、その他） ・世界の医療用テープ・包帯市場規模：エンドユーザー別（病院、ASC、クリニック、在宅医療、その他） ・世界の医療用テープ・包帯市場規模：地域別...“The medical tapes and bandages market is projected to reach USD 8.6 Billion by 2026 from USD 7.1 Billion in 2021, at a CAGR of 4.0 % during the forecast period.” The rising number of surgeries, increasing incidence of chronic wounds, and rising geriatric population are the major factors that are expected to drive the growth of the medical tapes and bandages market during the forecast period. However, the rising awareness about advanced wound care products is expected to restrain market growth in the coming years. “In terms Application, the surgical wound treatment segment is expected to account for the...
  • 世界の手術用ロボット市場予測：製品・サービス別、用途別、エンドユーザー別
    MD6781 / MarketsandMarkets / 2021年5月6日 / マーケッツアンドマーケッツ社は世界の手術用ロボット市場規模が2021年64億ドルから2026年144億ドルまで、年平均17.6%成長すると予測しています。本調査レポートでは、手術用ロボットの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別（器具・付属品、ロボットシステム、サービス）分析、用途別（一般手術、婦人科手術、整形手術、泌尿器手術、脳神経手術、その他）分析、エンドユーザー別（病院、外来手術センター）分析、地域別分析、競争状況、企業情報などを掲載しております。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・世界の手術用ロボット市場規模：製品・サービス別（器具・付属品、ロボットシステム、サービス） ・世界の手術用ロボット市場規模：用途別（一般手術、婦人科手術、整形手術、泌尿器手術、脳神経手術、その他） ・世界の手術用ロボット市場規模：エンドユーザー別（病院、外来手術センター） ・世界の手術用ロボット市場規模：地域別...“The global surgical robots market is projected to reach USD 14.4 billion by 2026 from USD 6.4 billion in 2021, at a CAGR of 17.6% during the forecast period.” Surgical robots enable surgeons to carry out complex surgical procedures with greater precision. They are primarily used in gynecological, urological, orthopedic, general, neurosurgeries, and other minimally invasive surgeries. Growth in this market is primarily driven by the advantages of robotic-assisted surgery, technological advancements in surgical robots, the increasing adoption of surgical robots, and the increase in funding for medical robot research. On the other hand, the high cost of robotic systems...
  • 世界の次世代シーケンシング（NGS）市場予測：製品＆サービス別、技術別、用途別、エンドユーザー別
    BT2697 / MarketsandMarkets / 2029年4月23日 / マーケッツアンドマーケッツ社は、世界の次世代シーケンシング（NGS）市場規模が2021年103億ドルから2026年242億ドルまで、年平均18.7％成長すると予測しています。本調査レポートでは、次世代シーケンシング（NGS）の世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品＆サービス別（NGS消耗品、シーケンシングサービス、製品・サービス事前調査/サンプル準備、NGSプラットフォーム、バイオインフォマティクス）分析、技術別（SBS、イオン半導体シーケンシング、ナノポアシーケンシング、単一分子リアルタイムシーケンシング、その他）分析、用途別（診断、創薬、農業＆動物研究、その他）分析、エンドユーザー別（学術機関＆研究センター、製薬＆バイオテクノロジー企業、病院＆クリニック、その他）分析、地域別分析、競争状況、企業情報などを整理しました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・世界の次世代シーケンシング（NGS）市場規模：製品＆サービス別（NGS消耗品、シーケンシングサービス、製品・サービス事前調査/サンプル準備、NGSプラットフォーム、バイオインフォマティクス） ・世界の次世代シーケンシング（NGS）市場規模：技術別（SBS、イオン半導体シーケンシング、ナノポアシーケンシング、単一分子リアルタイムシーケンシング、その他） ・世界の次世代シーケンシング（NGS）市場規模：用途別（診断、創薬、農業＆動物研究、その他） ・世界の次世代シーケンシング（NGS）市場規模：エンドユーザー別（学術機関＆研究センター、製薬＆バイオテクノロジー企業、病院＆クリニック、その他）...“The next-generation sequencing market is projected to reach USD 24.2 billion by 2026 from USD 10.3 billion in 2021, at a CAGR of 18.7% during the forecast period, owing to availability of advanced NGS systems at low costs, and favorable funding scenario for precision medicine.” “By product & service, the NGS consumables segment accounted for the largest share of the next-generation sequencing market” The next-generation sequencing market by product is categorized into major consumables and equipments. NGS consumables dominated the market in 2020. The large share of this segment can be attributed to growing number of sequencing procedures and launch...
  • 世界の分子生物学用酵素・キット・試薬市場予測：製品別、用途別、エンドユーザー別、地域別
    BT2612 / MarketsandMarkets / 2021年5月28日 / マーケッツアンドマーケッツ社は世界の分子生物学用酵素・キット・試薬市場規模が2021年153億ドルから2026年297億ドルまで、年平均14.2％成長すると予想しています。本市場調査レポートでは、分子生物学用酵素・キット・試薬の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（キット・試薬、酵素）分析、用途別（ポリメラーゼ連鎖反応（PCR）、シーケンス、クローン、エピジェネティクス、合成生物）分析、エンドユーザー別（学術・研究機関、病院・診断センター、製薬・バイオテクノロジー企業、その他）分析、地域別分析、競争状況、企業情報など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・世界の分子生物学用酵素・キット・試薬市場規模：製品別（キット・試薬、酵素） ・世界の分子生物学用酵素・キット・試薬市場規模：用途別（ポリメラーゼ連鎖反応（PCR）、シーケンス、クローン、エピジェネティクス、合成生物） ・世界の分子生物学用酵素・キット・試薬市場規模：エンドユーザー別（学術・研究機関、病院・診断センター、製薬・バイオテクノロジー企業、その他） ・世界の分子生物学用酵素・キット・試薬市場規模：地域別...“The global molecular biology enzymes and kits & reagents market is projected to USD 29.7 billion by 2026 from USD 15.3 billion in 2021, at a CAGR of 14.2% during the forecast period.” The rising number of genome projects coupled with reducing genetic analysis costs helps advance research in various domains, such as disease treatment, personalized medicine, and microbial genetics. These processes require the use of various molecular biology enzymes and reagents and are thus expected to drive the molecular biology enzymes and kits & reagents market. However, factors such as limited reimbursements for genetic testing is likely to hinder...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆